Abstract:Age impacts alloimmunity. Effects of aging on T‐cell metabolism and the potential to interfere with immunosuppressants have not been explored yet. Here, we dissected metabolic pathways of CD4+ and CD8+ T cells in aging and offer novel immunosuppressive targets. Upon activation, CD4+ T cells from old mice failed to exhibit adequate metabolic reprogramming resulting into compromised metabolic pathways, including oxidative phosphorylation (OXPHOS) and glycolysis. Comparable results were also observed in elderly human patients. Although glutaminolysis remained the dominant and age‐independent source of mitochondria for activated CD4+ T cells, old but not young CD4+ T cells relied heavily on glutaminolysis. Treating young and old murine and human CD4+ T cells with 6‐diazo‐5‐oxo‐l‐norleucine (DON), a glutaminolysis inhibitor resulted in significantly reduced IFN‐γ production and compromised proliferative capacities specifically of old CD4+ T cells. Of translational relevance, old and young mice that had been transplanted with fully mismatched skin grafts and treated with DON demonstrated dampened Th1‐ and Th17‐driven alloimmune responses. Moreover, DON diminished cytokine production and proliferation of old CD4+ T cells in vivo leading to a significantly prolonged allograft survival specifically in old recipients. Graft prolongation in young animals, in contrast, was only achieved when DON was applied in combination with an inhibition of glycolysis (2‐deoxy‐d‐glucose, 2‐DG) and OXPHOS (metformin), two alternative metabolic pathways. Notably, metabolic treatment had not been linked to toxicities. Remarkably, immunosuppressive capacities of DON were specific to CD4+ T cells as adoptively transferred young CD4+ T cells prevented immunosuppressive capacities of DON on allograft survival in old recipients. Depletion of CD8+ T cells did not alter transplant outcomes in either young or old recipients. Taken together, our data introduce an age‐specific metabolic reprogramming of CD4+ T cells. Targeting those pathways offers novel and age‐specific approaches for immunosuppression.

Defective respiration and one-carbon metabolism contribute to impaired naïve T cell activation in aged mice

Extracellular Delivery of Functional Mitochondria Rescues the Dysfunction of CD4+ T Cells in Aging

Age-associated remodeling of T cell immunity and metabolism

Targeting Aging: Lessons Learned From Immunometabolism and Cellular Senescence

Critical role of the CD44lowCD62Llow CD8+ T cell subset in restoring antitumor immunity in aged mice

Targeting age‐specific changes in CD4 + T cell metabolism ameliorates alloimmune responses and prolongs graft survival

The aged tumor microenvironment limits T cell control of cancer

Age-associated increase in lifespan of naïve CD4 T cells contributes to T-cell homeostasis but facilitates development of functional defects

Mitochondrial Oxidative Stress Regulates FOXP3+ T-Cell Activity and CD4-Mediated Inflammation in Older Adults with Frailty

Functionally Diverse NK-Like T Cells Are Effectors and Predictors of Successful Aging

Reduced Bioenergetics and Toll-Like Receptor 1 Function in Human Polymorphonuclear Leukocytes in Aging

Physical activity modifies the metabolic profile of CD4+ and CD8+ T cell subtypes at rest and upon activation in older adults

Aging of the Immune System. Mechanisms and Therapeutic Targets

An aged immune system drives senescence and ageing of solid organs

Quantifiable blood TCR repertoire components associate with immune aging

Targeting macrophages rescues age-related immune deficiencies in C57BL/6J geriatric mice

Immunometabolic Regulation of Vaccine-Induced Antibody Responses in Aging Mice

Haem toxicity in the aged spleen impairs T-cell immunity through iron deprivation

Hallmarks of the aging T‐cell system

Restoration of LAMP2A expression in old mice leads to changes in the T cell compartment that support improved immune function

Quantifiable Blood TCR Repertoire Components Associated with Immune Aging